Clinical Trial Update: Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients. [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial compared tiotropium 18 mcg once daily with salmeterol 50 mcg twice daily in COPD patients to assess time to first exacerbation; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Serevent (salmeterol)
• Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2011-05-17